Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and Bacteremia

moxifloxacin has been researched along with Bacteremia in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's13 (76.47)29.6817
2010's4 (23.53)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bryk, A; Kanervo-Nordström, A; Könönen, E; Niemi, P1
Drekonja, DM1
Darley, DR; Glanville, AR; Goeman, EE; Jensen, TO; Marriott, DJ; Shaw, K1
Adachi, J; Georgescu, G; Isola, IM; Rolston, K; Youssef, S1
Aracil, B; Campos, J; Cuevas, O; de Abajo, F; García-Cobos, S; Lázaro, E; Ortega, A; Oteo, J1
Arenz, D; Böll, B; Bredenfeld, H; Chemnitz, J; Cornely, OA; Cremer, B; Hallek, M; Kaul, I; Klein, F; Mahne, M; Moritz, G; Scheid, C; Vehreschild, JJ; Vehreschild, MJ; Wassmer, G1
Goldstein, EJ1
Elliott, MA; Patel, R; Prabhu, RM1
Alvarez, M; Diz, P; Limeres, J; López-Meléndez, C; Otero, JL; Saavedra, E; Tomás, I1
Georgopoulos, A; Graninger, W; Grisold, AJ; Hirschl, AM; Presterl, E; Reichmann, S1
Bommer, M; Döhner, H; Kern, P; Kern, WV; Marre, R; Reuter, S; Sigge, A; von Baum, H1
Alvarez Fernández, M; Diz Dios, P; Fernández Feijoo, J; Limeres Posse, J; Medina Henríquez, J; Tomás Carmona, I1
Collignon, A; Cruaud, P; Gaudelus, J; Jacquier, H; Lachassinne, E; Poilane, I1
Groeneveld, JH; Kuijper, EJ; van Nieuwkoop, C; Visser, LG1
Amsterdam, D; Hardy, D; Mandell, LA; Rotstein, C1
Friedrich, A; Martino, P; Micozzi, A; Monaco, M; Tarasi, A; Venditti, M1
Picazo, JJ; Rodríguez-Avial, C; Rodríguez-Avial, I1

Trials

2 trial(s) available for moxifloxacin and Bacteremia

ArticleYear
Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Aza Compounds; Bacteremia; Bacterial Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Neutropenia; Pilot Projects; Placebos; Prospective Studies; Quinolines; Stem Cell Transplantation; Treatment Outcome

2012
Comparative efficacies of amoxicillin, clindamycin, and moxifloxacin in prevention of bacteremia following dental extractions.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:9

    Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteremia; Clindamycin; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Prospective Studies; Quinolines; Streptococcal Infections; Streptococcus; Tooth Extraction

2006

Other Studies

15 other study(ies) available for moxifloxacin and Bacteremia

ArticleYear
Antimicrobial susceptibilities of Peptostreptococcus anaerobius and the newly described Peptostreptococcus stomatis isolated from various human sources.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteremia; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Peptostreptococcus; Species Specificity

2007
Erysipelothrix bacteremia without endocarditis: rare event or under-reported occurrence?
    Diagnostic microbiology and infectious disease, 2013, Volume: 77, Issue:3

    Topics: Anti-Bacterial Agents; Aza Compounds; Bacteremia; Echocardiography, Transesophageal; Endocarditis, Bacterial; Endocardium; Erysipelothrix; Erysipelothrix Infections; Fluoroquinolones; Hand; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Treatment Outcome

2013
Donor-derived tuberculosis (TB): isoniazid-resistant TB transmitted from a lung transplant donor with inadequately treated latent infection.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:5

    Topics: Adult; Allografts; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antitubercular Agents; Bacteremia; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cystic Fibrosis; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Immunosuppression Therapy; Isoniazid; Latent Tuberculosis; Lung Transplantation; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Pseudomonas aeruginosa; Rifampin; Tissue Donors; Tuberculosis, Pulmonary

2016
Disseminated salmonellosis in a patient treated with temozolomide.
    The Journal of infection, 2008, Volume: 57, Issue:5

    Topics: Adult; Anti-Infective Agents; Antineoplastic Agents, Alkylating; Arthritis, Infectious; Astrocytoma; Aza Compounds; Bacteremia; Brain Neoplasms; Dacarbazine; Drainage; Fluoroquinolones; Focal Infection; Humans; Immunocompromised Host; Male; Moxifloxacin; Quinolines; Salmonella Infections; Temozolomide

2008
Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/clavulanic acid.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Aza Compounds; Bacteremia; Drug Resistance, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Hospitals; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Spain; Young Adult

2011
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Sep-01, Volume: 35, Issue:Suppl 1

    Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones

2002
Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Apr-01, Volume: 38, Issue:7

    Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Female; Fluoroquinolones; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Neutropenia; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Treatment Failure

2004
In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain.
    Oral microbiology and immunology, 2004, Volume: 19, Issue:5

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Drug Resistance, Bacterial; Female; Fluoroquinolones; Focal Infection, Dental; Humans; Iatrogenic Disease; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Quinolines; Spain; Statistics, Nonparametric; Streptococcal Infections; Streptococcus; Tooth Extraction

2004
Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Biofilms; Blood; Culture Media; Endocarditis, Bacterial; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Neutropenia; Penicillins; Quinolines; Streptococcal Infections; Teicoplanin; Viridans Streptococci

2005
Moxifloxacin prophylaxis in neutropenic patients.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:4

    Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteremia; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Moxifloxacin; Neutropenia; Ofloxacin; Quinolines

2006
[In vitro activity of moxifloxacin (8-methoxyquinolone) alone or in combination with cefotaxime against group B streptococci].
    Pathologie-biologie, 2007, Volume: 55, Issue:8-9

    Topics: Anti-Bacterial Agents; Aza Compounds; Bacteremia; Cefotaxime; Drug Therapy, Combination; Fluoroquinolones; Humans; Infant, Newborn; Meningitis, Bacterial; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Serotyping; Streptococcal Infections; Streptococcus agalactiae

2007
Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin.
    The Journal of infection, 2008, Volume: 56, Issue:2

    Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Chronic Disease; Enterococcus faecalis; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Moxifloxacin; Prostatitis; Quinolines; Recurrence; Treatment Outcome

2008
Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:3

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Fluoroquinolones; Gemifloxacin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines

2000
In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2001, Volume: 7, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteremia; Blood; Fluoroquinolones; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Stenotrophomonas maltophilia

2001
[In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2001, Volume: 14, Issue:4

    Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Norfloxacin; Ofloxacin; Penicillins; Quinolines; Streptococcal Infections; Streptococcus

2001